AdaptHealth Corp. Quarterly Deferred Income Tax Expense (Benefit) in USD from Q1 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
AdaptHealth Corp. quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from Q1 2019 to Q1 2024.
  • AdaptHealth Corp. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was $4.39M.
  • AdaptHealth Corp. annual Deferred Income Tax Expense (Benefit) for 2023 was -$62.6M, a 447% decline from 2022.
  • AdaptHealth Corp. annual Deferred Income Tax Expense (Benefit) for 2022 was $18M, a 19.4% decline from 2021.
  • AdaptHealth Corp. annual Deferred Income Tax Expense (Benefit) for 2021 was $22.4M.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $4.39M +$6.72M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q1 2023 -$2.33M -$6.63M -154% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q1 2022 $4.3M +$6M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q1 2021 -$1.7M +$574K +25.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q1 2020 -$2.27M -$3.75M -253% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q1 2019 $1.48M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.